Studienserver - Medizinische Hochschule Hannover

Studien: Lenalidomid vs. Placebo beim 5q- Syndrom

ID Studie

Clinicaltrials.gov Identifier

Beschreibung

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study of the Efficacy and Safety of 2 Doses of Lenalidomide Versus Placebo in Red Blood Cell (RBC) Transfusion-Dependent Subjects With Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated With a Deletion 5Q Cytogenetic Abnormality

Status